Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Interested in Binary Options?
We'll teach you the best ways to trade binaries.
...
Health Technology » Pharmaceuticals Major
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| JNJ | Johnson & Johnson | -0.03% | 160.65 | 0.7% | $1221.27m | |
| PFE | Pfizer Inc. | 0.33% | 37.73 | 0.9% | $1019.62m | |
| MRK | Merck & Co., Inc. | 0.27% | 76.88 | 0.7% | $968.36m | |
| ABBV | AbbVie, Inc. | -0.14% | 106.75 | 1.9% | $826.86m | |
| BMY | Bristol-Myers Squibb Co. | 0.40% | 64.71 | 1.0% | $734.69m | |
| LLY | Eli Lilly & Co. | 0.51% | 186.96 | 1.1% | $580.48m | |
| AZN | AstraZeneca Plc | 0.14% | 50.90 | 1.2% | $443.12m | |
| GSK | GlaxoSmithKline Plc | 0.40% | 37.82 | 0.2% | $214.84m | |
| RPRX | Royalty Pharma Plc | 0.00% | 41.65 | 0.2% | $157.73m | |
| NVS | Novartis AG | 0.26% | 87.43 | 0.2% | $153.87m | |
| VTRS | Viatris, Inc. | 0.45% | 13.34 | 0.0% | $128.74m | |
| CVAC | CureVac NV | 3.80% | 108.00 | 0.0% | $90.78m | |
| RGEN | Repligen Corp. | 0.00% | 213.57 | 6.8% | $89.09m | |
| ATNF | 180 Life Sciences Corp. | 0.70% | 10.11 | 0.0% | $61.23m | |
| SNY | Sanofi | 0.43% | 50.91 | 0.2% | $61.17m |
Company Profile
Pfizer Inc. engages in the discovery, development, and manufacture of healthcare products specializes in medicines, vaccine, and consumer healthcare. It operates through the Pfizer Innovative Health (IH) and Pfizer Essential Health (EH) segments. The IH segment focuses on the development and commercializing medicines and vaccines for internal medicine, oncology, inflammation and immunology, rate disease, and consumer healthcare. The EH segment is involved in development and supply of branded generics, generic sterile injectable products, biosimilars, and select branded products including anti-infectives. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.